BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 28842145)

  • 1. Cost-Effectiveness of Multidisciplinary Management Program and Exercise Training Program in Heart Failure.
    Dang W; Yi A; Jhamnani S; Wang SY
    Am J Cardiol; 2017 Oct; 120(8):1338-1343. PubMed ID: 28842145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of supervised exercise therapy in heart failure patients.
    Kühr EM; Ribeiro RA; Rohde LE; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S100-7. PubMed ID: 21839879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management.
    Grustam AS; Severens JL; De Massari D; Buyukkaramikli N; Koymans R; Vrijhoef HJM
    Value Health; 2018 Jul; 21(7):772-782. PubMed ID: 30005749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year cost-effectiveness of supervised center-based exercise training in addition to a post-discharge disease management program for patients recently hospitalized with acute heart failure: The EJECTION-HF study.
    Maru S; Mudge AM; Suna JM; Scuffham PA;
    Heart Lung; 2019; 48(5):414-420. PubMed ID: 31000333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failure.
    Moertl D; Steiner S; Coyle D; Berger R
    Int J Technol Assess Health Care; 2013 Jan; 29(1):3-11. PubMed ID: 23257208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
    Pradelli L; Iannazzo S; Zaniolo O
    Am J Cardiovasc Drugs; 2009; 9(6):383-92. PubMed ID: 19929036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
    Retèl VP; van der Molen L; Hilgers FJ; Rasch CR; L'Ortye AA; Steuten LM; van Harten WH
    BMC Cancer; 2011 Nov; 11():475. PubMed ID: 22051143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
    van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
    Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication.
    van den Houten MM; Lauret GJ; Fakhry F; Fokkenrood HJ; van Asselt AD; Hunink MG; Teijink JA
    Br J Surg; 2016 Nov; 103(12):1616-1625. PubMed ID: 27513296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
    Retèl VP; van der Molen L; Steuten LM; van den Brekel MW; Hilgers FJ
    Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):709-18. PubMed ID: 25666587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.
    Alba AC; Alba LF; Delgado DH; Rao V; Ross HJ; Goeree R
    Circulation; 2013 Jun; 127(24):2424-35. PubMed ID: 23697907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome.
    Tak CR; Biltaji E; Kohlmann W; Maese L; Hainaut P; Villani A; Malkin D; Sherwin CMT; Brixner DI; Schiffman JD
    Pediatr Blood Cancer; 2019 May; 66(5):e27629. PubMed ID: 30719841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Evaluation of Exercise-Based Cardiac Rehabilitation Programs for Chronic Heart Failure Patients in Colombia.
    Rincón M; Rojas MX; Rodriguez Romero VA; Tamayo DC; Franco C; Castro H; Brophy J; Dennis R
    J Cardiopulm Rehabil Prev; 2016; 36(1):12-9. PubMed ID: 26702862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
    Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
    Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial Results.
    Bocchi EA; da Cruz FDD; BrandÃo SM; Issa V; Ayub-Ferreira SM; Brunner la Rocca HP; Wijk SS
    J Card Fail; 2018 Oct; 24(10):627-637. PubMed ID: 29723595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
    de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
    Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
    Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
    J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up.
    Gordon LG; Eakin EG; Spence RR; Pyke C; Bashford J; Saunders C; Hayes SC
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33228174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results.
    Pawęska J; Macioch T; Perkowski P; Budaj A; Niewada M
    Kardiol Pol; 2014; 72(9):823-30. PubMed ID: 24846362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.